The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial - Wikidata - wikimedia - TriplyDB

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

http://www.wikidata.org/entity/Q24676550

about

Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review Antiepileptic drug monotherapy for epilepsy: a network meta-analysis Antiepileptic drugs for the primary and secondary prevention of seizures after stroke Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures Antiepileptic drugs for the primary and secondary prevention of seizures after stroke Lamotrigine add-on for refractory generalized tonic-clonic seizures Valproate in the treatment of epilepsy in girls and women of childbearing potential Old versus New: Why Do We Need New Antiepileptic Drugs?Outcomes of sustained-release formulation of valproate and topiramate monotherapy in patients with epilepsy: a multi-centre, cohort study The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repository A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy Exploring changes over time and characteristics associated with data retrieval across individual participant data meta-analyses: systematic review Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation.Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.Misdiagnosis in epilepsy: a review and recognition of diagnostic uncertainty.The adolescent or adult with generalized tonic-clonic seizures.Time to 12-month remission and treatment failure for generalised and unclassified epilepsy.Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study Valproate in children with newly diagnosed idiopathic generalized epilepsy.Review of topiramate for the treatment of epilepsy in elderly patients.Epilepsy (generalised)Resource implications of preparing individual participant data from a clinical trial to share with external researchers.The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs Seizure control in patients with idiopathic generalized epilepsies: EEG determinants of medication response.Treatment outcome after failure of a first antiepileptic drug.Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy.The treatment of women with epilepsy.What are the Therapeutic Advances in Neurology? Opinions from World Experts.Comparing drug treatments in epilepsy.Treating epilepsy across its different stages.Practice Update: Review of Anticonvulsant Therapy.Complete remission of childhood-onset epilepsy: stability and prediction over two decades Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.Emerging drugs for epilepsy.Multiple treatment comparisons in epilepsy monotherapy trials.POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders

P2860

Q24186683-1308402D-E90F-4F20-A415-2A240D877684 Q24187678-4825F0F1-9ED7-4714-B63F-784436B6A16A Q24201007-A786D69F-2A44-4BB7-8AD5-141D6671F238 Q24235599-8133A646-F669-42E5-8E0A-FEDF47B974B4 Q24240330-E91C73A7-3EB4-4022-ABE7-CBCCFB2FA1A8 Q24240784-A0063A17-1F07-4CB8-A2D4-A05956769CCF Q26865670-FB469955-9E69-4F55-995F-AA4EB006AF9A Q28082225-ACA56F0C-ED89-4A78-9F88-29BD3DE81156 Q28484278-C0387B72-851F-4EA5-900E-140914342F32 Q28547386-F6F94281-FCFD-485D-8AF8-B300DAC51C31 Q28564629-E76138E5-4AEE-4664-8371-9ADF411C2795 Q28659066-F28DF06E-9FF7-4514-B732-D70681386B5F Q28943418-ECCE4155-BCBB-4FE1-BA4E-65D9CB685CF9 Q29994664-D56EE205-723E-4A13-8538-D05398B97ADF Q30489831-1FC1DC94-6A5C-4AD1-8091-3C6EEB1ED223 Q30498029-E41D6F43-55A0-4ACA-91A4-098968E8B3B6 Q31147165-0F43A187-1299-4059-9D6F-DA44BFC56F34 Q33156564-13019CB7-F024-47CC-95E8-3E4F4B4E5401 Q33161273-A35D4235-8754-463A-944B-7E8D63AF0BA0 Q33658630-2CCA2627-F1E9-43B0-99DC-7C884AA2B27A Q33665151-0673970D-D53F-4F4A-802E-1193E2529825 Q33711209-7BB0E0C5-232B-4675-BE8B-1EB74EE9F369 Q33819386-520B9B04-F014-4999-985C-8BA734369B27 Q33850495-11471DFA-45AC-4967-AA8B-99271C96976E Q33909155-96601BE5-69B2-458B-8A68-6D3A901A5BBB Q33970119-32AB3959-D52A-4B55-ACAD-8B7048B7A77F Q34071733-C4E1EFC0-494C-4BD4-8F54-72DEF0F444EF Q34079336-A01AD692-5AAA-43F5-8F50-C3D3E0CAABFB Q34343400-D661A0A0-3ADA-4D64-BAD6-D1F0BE8137B4 Q34363064-AE235D32-7384-46BE-9417-A649F6B4C438 Q34409057-3BF5F700-F5F1-415A-8DF8-FB3DFCC71EA9 Q34409373-ADC63794-2882-4D2C-8BE4-B3CD6167726E Q34409465-6C39D196-7548-44FF-AA0D-A55A97891724 Q34518509-E05B91AE-3BE3-4962-9D60-20FD7B5DCEC5 Q34556031-C04ACFD7-59D1-4FB2-887E-9DC25AF2F23E Q34563933-BC0DB0B1-CCFE-4513-863E-6C95004385A4 Q34590331-1B84EEF8-6E98-4C6A-9918-25068376A5BC Q34688725-C7CA79EF-9421-4703-9078-3A4C3F2F1BF3 Q34710058-A40F4159-3DC7-4DBF-97D2-F9E918442613 Q34997170-366B2C46-91E8-4786-B071-60A202722033

P2860

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

http://www.wikidata.org/entity/Q24676550

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The SANAD study of effectivene ...... ed randomised controlled trial

@ast

The SANAD study of effectivene ...... ed randomised controlled trial

@en

The SANAD study of effectivene ...... ed randomised controlled trial

@nl

type

label

The SANAD study of effectivene ...... ed randomised controlled trial

@ast

The SANAD study of effectivene ...... ed randomised controlled trial

@en

The SANAD study of effectivene ...... ed randomised controlled trial

@nl

prefLabel

The SANAD study of effectivene ...... ed randomised controlled trial

@ast

The SANAD study of effectivene ...... ed randomised controlled trial

@en

The SANAD study of effectivene ...... ed randomised controlled trial

@nl

P1433

Q24676550-FCB23423-91A6-4770-9C89-436F18827E44

P1476

Q24676550-757729EA-2E14-4D31-8E7F-D28955CB5CE4

P2093

Q24676550-0E074150-E90D-49BB-87BE-B38E06693793

Q24676550-0E5C4D40-C257-4577-9087-04A05CEFACAC

Q24676550-280DF376-1CB0-49F0-9A1C-DC440FFB13AC

Q24676550-3E4A5FA3-AA12-4A80-AD93-C88168D5DA7E

Q24676550-4CD07B2B-55E7-4432-BBD8-8C2D57E5D0EE

Q24676550-509152C8-60AA-4AE1-A18D-6B50AE73135E

Q24676550-529446DD-BFFC-4FF3-99A1-8DF91A888075

Q24676550-559B48A4-7D8B-4DBA-AF1C-C096D9D869EF

Q24676550-731DCB9E-6AF5-465D-A7F6-5AFCC74E071E

Q24676550-75F2FD7E-6E75-4293-8AFF-5089D2154D0B

P2860

Q24676550-119EE5B0-5527-485F-917F-7D15B286106D

Q24676550-2BE7E29D-D5AD-4911-BE14-1B8AB2D6FCC4

Q24676550-54A9204C-05A9-4E32-8ED3-5E208D37C73E

Q24676550-580C776A-0F56-4945-A583-0AAAB499B05F

Q24676550-899064DE-F914-485B-A193-F3BE986484FA

Q24676550-8A96ACE2-A5FC-42FE-B123-1150903BF282

Q24676550-A5B20460-6651-40D8-AD7F-C975DE650FC7

Q24676550-AED97280-3073-4BEB-8E6A-C44C6B80F1C1

Q24676550-AFAE4603-53CC-49E5-9F14-EAA29F380DCB

Q24676550-B4E23AB5-8225-4210-B629-1FBD97A13272

P304

Q24676550-03E4AA4B-7FA2-4DA2-9A15-49AEBF7305FF

P31

Q24676550-D12AB748-6826-4742-B7B9-7E2577C39CAC

P3181

Q24676550-A4195F14-0A0B-4827-8374-D65FB027C670

P356

Q24676550-7054C362-153B-407F-92DF-D5B10DA29D42

P407

Q24676550-C4F1EFBD-8115-415D-B6CC-E879997831A5

P433

Q24676550-5D13CD4A-45DD-48D6-9FE2-38845F5042D9

P478

Q24676550-3E9FFC11-0A23-422E-AD69-511C8E1427D2

P50

Q24676550-03F2985B-1F66-4344-A441-85E1FAA2F247

Q24676550-A1C135AF-B135-4C39-9641-5229EB3ACDE5

Q24676550-FCEC4BDF-68CF-451D-9A9F-C0F5849B0BDE

P577

Q24676550-D053C007-5BC9-4C64-A20B-41D4201C2959

P698

Q24676550-2605EB16-DAB2-4FFF-AC9F-15B61D01B790

P932

Q24676550-3058F06D-9D48-4DBD-9AB4-CA1B594C640C

P3181

P356

S0140-6736(07)60461-9

P1433

P1476

The SANAD study of effectivene ...... ed randomised controlled trial

@en

P2093

Adrian Hughes

http://www.w3.org/2001/XMLSchema#string

Alessandra Vanoli

http://www.w3.org/2001/XMLSchema#string

Ann Jacoby

http://www.w3.org/2001/XMLSchema#string

Anthony G Marson

http://www.w3.org/2001/XMLSchema#string

Asya M Al-Kharusi

http://www.w3.org/2001/XMLSchema#string

Barbara Eaton

http://www.w3.org/2001/XMLSchema#string

Celia Cramp

http://www.w3.org/2001/XMLSchema#string

David F Smith

http://www.w3.org/2001/XMLSchema#string

David W Chadwick

http://www.w3.org/2001/XMLSchema#string

Geoffrey R Lawson

http://www.w3.org/2001/XMLSchema#string

P2860

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents

The longer term outcome of children born to mothers with epilepsy

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis.

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American E

Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.

Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies.

P304

1016-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3563817

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(07)60461-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

9566

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Paula Williamson

Catrin Tudur Smith

P577

2007-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17382828

http://www.w3.org/2001/XMLSchema#string

P932

2039891

http://www.w3.org/2001/XMLSchema#string